Table 2. The number of patients within the prostate cancer cohort that were dichotomously categorised for each biomarker.
Biomarker (score) | Number of cancer patients scored | Number positive (%) | Number negative (%) |
---|---|---|---|
Ki67 (>110) | 161 | 11 (6.8) | 150 (93.2) |
DLX2 (>10) | 185 | 135 (73) | 50 (27) |